DWS has invested an undisclosed sum to buy a radiotherapy platform provider in Germany on behalf of its third pan-European infrastructure (PEIF III) fund

The manager’s PEIF III fund – which announced a €3bn fundraise in June – has acquired RadioOnkologieNetzwerk (RON) in partnership with the founders, Sandra Röddiger and Ralf Kurek.

RON operates the largest radiotherapy network in Germany with 17 different sites across five states in the country.

DWS said RON will be combined with the manager’s existing investment in Medipass to l create a leading European provider of cancer care and advanced diagnostic imaging services.

The combined company will benefit from an existing presence in Germany, Italy and the UK.

DWS said it expects to support the company’s expansion plan through both the acquisition of new clinics and organic growth via new outsourcing contracts with hospitals, in existing and new countries, such as France, Austria and Switzerland.

Hamish Mackenzie, the head of Infrastructure at DWS, said: “We look forward to working with hospitals and clinicians across Europe to achieve our shared vision of providing an increasing number of patients with these essential high-quality cancer care services across the continent.”

Röddiger and Kurek, co-CEOs at RON said: “Both DWS and Medipass share our deep conviction that the combination of a management team led by doctors, cutting-edge medical technology paired with genuine empathy for our seriously ill patients are the key factors for continued successful growth.”

Guglielmo Brayda Di Soleto, CEO at Medipass, said: “Medipass and RON share a common vision and strategy, using a medical-focussed approach and state-of-the-art equipment to provide hospitals and patients with optimised treatment solutions, which will be an innovative, solid and effective support in cancer care.”

To read the digital edition of the latest IPE Real Assets magazine click here.